Fig 2.
Effect size maps for all patients compared with control participants and patients with 6-OPRI compared with control participants. Effect size maps demonstrating the percentage difference between patients with 6-OPRI and controls in (A) gray matter volume and (B) WM volume calculated as 100*(controls-all patients)/controls displayed in the Montreal Neurological Institute space.